IC-8 Apthera Intraocular Lens (IOL)

FDA Premarket Approval P210005

Pre-market Approval Supplement Details

DeviceIC-8 Apthera Intraocular Lens (IOL)
Generic NameExtended Depth Of Focus Intraocular Lens
ApplicantAcuFocus, Inc.32 Discoverysuite 200irvine, CA 92618 PMA NumberP210005 Date Received02/24/2021 Decision Date07/22/2022 Product Code POE  Advisory Committee Ophthalmic Clinical TrialsNCT03633695 Expedited Review Granted? No
Date Received2021-02-24
Decision Date2022-07-22
PMAP210005
SupplementS
Product CodePOE 
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination ProductNo
Applicant AddressAcuFocus, Inc.
32 Discovery
suite 200
irvine, CA 92618 PMA NumberP210005 Date Received02/24/2021 Decision Date07/22/2022 Product Code POE  Advisory Committee Ophthalmic Clinical TrialsNCT03633695
Expedited Review Granted? No Combination ProductNo Approval Order Statement  
The IC-8 Apthera IOL Is Indicated For Unilateral Implantation For The Visual Correction Of Aphakia And To Create Monovision In Patients Of Age 22 Or Older Who Have Been Diagnosed With Bilateral Operable Cataract, Who Have Up To 1.5 D Of Astigmatism In The Implanted Eye, And Who Do Not Have A History Of Retinal Disease And Who Are Not Predisposed To Experiencing Retinal Disease In The Future. The Device Is Intended For Primary Implantation In The Capsular Bag, In The Non-dominant Eye, After The Fellow Eye Has Already Undergone Successful Implantation (uncorrected Distance Visual Acuity 20/32 Or Better And Best-corrected Distance Visual Acuity 20/25 Or Better) Of A Monofocal Or Monofocal Toric IOL That Is Targeted For Emmetropia. The Refractive Target For The IC-8 Apthera IOL Should Be -0.75 D. The Lens Mitigates The Effects Of Presbyopia By Providing An Extended Depth Of Focus. Compared To An Aspheric Monofocal Or Monofocal Toric IOL, The Lens Provides Improved Intermediate And Near Visual Acuity, While Maintaining Comparable Distance Visual Acuity. Supplements:  

Supplemental Filings

Supplement NumberDateSupplement Type
P210005Original Filing
S004 2022-11-04 Normal 180 Day Track No User Fee
S003
S002 2022-08-23 Normal 180 Day Track No User Fee
S001 2022-08-23 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00813359020731 P210005 000
00813359020847 P210005 000
00813359020854 P210005 000
00813359020861 P210005 000
00813359020878 P210005 000
00813359020885 P210005 000
00813359020892 P210005 000
00813359020908 P210005 000
00813359020915 P210005 000
00813359020830 P210005 000
00813359020823 P210005 000
00813359020748 P210005 000
00813359020755 P210005 000
00813359020762 P210005 000
00813359020779 P210005 000
00813359020786 P210005 000
00813359020793 P210005 000
00813359020809 P210005 000
00813359020816 P210005 000
00813359020922 P210005 000
00813359020939 P210005 000
00813359020946 P210005 000
00813359021059 P210005 000
00813359021066 P210005 000
00813359021073 P210005 000
00813359021080 P210005 000
00813359021097 P210005 000
00813359021103 P210005 000
00813359021110 P210005 000
00813359021127 P210005 000
00813359021042 P210005 000
00813359021035 P210005 000
00813359020953 P210005 000
00813359020960 P210005 000
00813359020977 P210005 000
00813359020984 P210005 000
00813359020991 P210005 000
00813359021004 P210005 000
00813359021011 P210005 000
00813359021028 P210005 000
00813359021134 P210005 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.